Doloromics
Menlo Park
About Doloromics
Doloromics, a pain therapeutics discovery company, is building a proprietary platform for the discovery of disease-specific pain mechanisms, biomarkers, and therapeutics.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $7.7M
- Funding stage: Seed
- Last round: Seed (Feb 2022)
- Website: doloromics.com
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/doloromics-26947 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.